- LCPD is a disease with a high risk of future complications such as osteoarthritis. MIV-711 has the potential to be the first drug to have a positive impact on disease progression, says
Read the full interview with
https://www.biostock.se/en/2024/05/double-thumbs-up-for-medivir-from-the-fda/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
https://news.cision.com/medivir/r/biostock-double-thumbs-up-for-medivir-from-the-fda,c3972938
(c) 2024 Cision. All rights reserved., source